Based on limited data available [28], de novo FL-BCL2R/MYC-R should not be included within the category of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.